MBS-COV
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MBS-COV, covering 2025-03-30 to 2025-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy Participants [Phase 1]